SAN ANTONIO – Hospitalization for an infection within the first year following diagnosis of primary nonmetastatic breast cancer is a red flag for increased risk of subsequent development of distant...
SAN ANTONIO – Two large phase III randomized trials comparing anastrozole and tamoxifen for prevention of disease recurrence in postmenopausal women with ductal carcinoma in situ were presented at...
SAN ANTONIO – Prophylactic beta-blockade with bisoprolol during adjuvant trastuzumab therapy for HER2-positive breast cancer prevented trastuzumab-induced decline in left ventricular ejection...
Uridine triacetate, a pyrimidine analogue, has been approved for the emergency treatment of fluorouracil or capecitabine overdoses in adults and children, and for patients who develop “certain severe...
COPENHAGEN – Sunlight is recognized as the 800-pound gorilla of melanoma risk, with roughly 65% of all melanomas worldwide attributable to exposure to UV radiation. But what about the other...
The use of androgen deprivation therapy (ADT) for treatment of prostate cancer was associated with increased risk of Alzheimer’s disease, and patients with greater duration of ADT use had higher...
Researchers detected circulating tumor cells (CTCs) in the portal venous blood of all patients with pancreaticobiliary cancer (PBC), but in the peripheral blood of only 22% of patients, according to...
ORLANDO – Women diagnosed with localized breast cancer while in their 70s have a higher mortality from cardiovascular disease than from their breast cancer, according to new data from the Women’s...
Chemotherapy and neoadjuvant chemotherapy are given more often to non-Hispanic black, Hispanic, and Asian women than to non-Hispanic white women with breast cancer, while black women saw a lower rate...
The Food and Drug Administration has approved nivolumab for the treatment of patients with metastatic renal cell carcinoma who have previously received antiangiogenic therapy, expanding on approval...
